Women and Lung Cancer Research and Preventive Services Act of 2024

Women and Lung Cancer Research and Preventive Services Act of 2023

This bill requires the Department of Health and Human Services to conduct an interagency review of the status of women and lung cancer. The review must

• report on the status of existing research and current knowledge gaps;
• identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
• provide recommendations for a national cancer screening strategy and public education campaign.

Bill 118 HR 4534, also known as the Women and Lung Cancer Research and Preventive Services Act of 2024, aims to address the disparities in lung cancer research and preventive services for women. The bill recognizes that lung cancer is the leading cause of cancer-related deaths among women in the United States, and that there is a lack of focus on women-specific research and preventive measures.

The key provisions of the bill include funding for research on the impact of lung cancer on women, as well as the development of preventive services tailored specifically for women. This includes increasing access to screenings, early detection methods, and treatment options that are effective for women.

Additionally, the bill calls for increased education and awareness campaigns targeted towards women, healthcare providers, and the general public. This is to ensure that women are informed about the risks of lung cancer and the importance of early detection and prevention. Overall, the Women and Lung Cancer Research and Preventive Services Act of 2024 seeks to address the gender disparities in lung cancer research and preventive services, with the goal of reducing the incidence and mortality rates of lung cancer among women in the United States.